摘要
目的研究Bc l-2在人类非小细胞肺癌中的表达与临床病理特征的关系。方法应用免疫组织化学(S-P法)检测80例非小细胞肺癌组织标本和40例肺良性病变组织中Bc l-2的表达水平。结果非小细胞肺癌组织中Bc l-2表达水平(51.2%)显著高于肺良性病变组织(12.5%)(P<0.01);非小细胞肺癌组织中Bc l-2表达水平升高与肺癌组织学类型存在相关性(P<0.05)。结论Bc l-2表达升高与肺癌的发生、发展关系密切。
Objective To investigate the expression of Bcl -2 and the relationship between the expression and the clinical pathology characteristic in non -small cell lung cancer (NSCLC). Methods The expression of Bcl -2 was detected in 80 NSCLC samples and 40 lung benign lesion tis- sues as control by immunohistochemistry( S - P). Results The expression level of Bcl - 2 was found to be significantly higher in NSCLC tissues than that in benign lesion tissues ( P 〈0.01 ) ;The expres- sion level of Bcl - 2 was closely related to histological classification in lung cancer patients ( P 〈 0.05 ). Conclusion The increasing of Bcl -2 expression is may be related to the pathogenesis and development of lung cancer.
出处
《医药论坛杂志》
2006年第4期8-9,共2页
Journal of Medical Forum
关键词
非小细胞肺癌
BCL-2
免疫组化
Non - small - cell lung cancer
Bcl - 2
Immunohistochemistry.